ART PRP Plus
Commercial- Indications
- Orthopedics, Aesthetics
Company intelligence / Profile preview
Celling Biosciences
Austin, Texas, United Statescellingbiosciences.com ↗
- Ownership
- Private
- Employees
- ~47
- Development stage
- Commercial
01
Overview
Celling Biosciences has developed and commercialized systems that enable physicians to collect, process, and deliver autologous cellular therapies at the point of care. The company claims to have pioneered the first system allowing users to regulate/select desired cell types via a patented collection window and integrated ultra-filtration system. No clinical trial results are publicly reported; products are used in clinical practice rather than as investigational drugs/devices.
- Therapeutic areas
- Other
- Modalities
- Cell therapyAutologous cell therapy
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on Celling Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Celling Biosciences.